stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / ABBV / Total Debt

AbbVie Inc. Total Debt 2012–2025

AbbVie Inc. (ABBV) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings. Compound growth +38.0%/yr over 13 years.

Fiscal yearTotal DebtChange (YoY)
FY 2025$67.00B+0.2%
FY 2024$66.84B+12.8%
FY 2023$59.24B-6.2%
FY 2022$63.13B-16.9%
FY 2021$75.98B-10.6%
FY 2020$84.98B+26.4%
FY 2019$67.23B+1717.6%
FY 2018$3.70B+824.8%
FY 2017$400.00M+6.1%
FY 2016$377.00M-7.1%
FY 2015$406.00M-4.5%
FY 2014$425.00M+2.9%
FY 2013$413.00M-59.5%
FY 2012$1.02B

Source: AbbVie Inc. SEC filings — balance sheet (10-K). Refreshed nightly.

See the full picture for AbbVie Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

AbbVie Inc. — frequently asked questions

What is AbbVie Inc.'s total debt (short- plus long-term borrowings)?

AbbVie Inc. (ABBV) reported total debt (short- plus long-term borrowings) of $67.00B for fiscal year 2025, per its SEC filings.

How has AbbVie Inc.'s total debt (short- plus long-term borrowings) changed over time?

Between fiscal 2012 and 2025, ABBV's total debt (short- plus long-term borrowings) grew at roughly 38.0% per year (compound annual rate), from $1.02B to $67.00B.

Where does this data come from?

Figures are computed from AbbVie Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.

More ABBV financial history

Full ABBV fundamentals page → · All 1,500+ companies →